Clinical Trials Browser

Phase 1 × Immunotherapy × 90 days × Clear all

NCT06974110 2026-01-16

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

GastrointestinalGynecologic

Neoplasm Metastasis, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms